US Stock MarketDetailed Quotes

NVO Novo-Nordisk A/S

Watchlist
  • 106.950
  • -1.660-1.53%
Close Dec 13 16:00 ET
  • 106.900
  • -0.050-0.05%
Post 19:59 ET
476.58BMarket Cap35.94P/E (TTM)

About Novo-Nordisk A/S Company

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsv?rd, Denmark.

Company Profile

SymbolNVO
Company NameNovo-Nordisk A/S
Listing DateJul 9, 1981
Founded1931
CEOMr. Lars Fruergaard Jorgensen
MarketNYSE
Employees64319
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
AddressNovo Allé 1
CityBagsv?rd
ProvinceCapital Region
CountryDenmark
Zip Code2880
Phone45-44-44-88-88

Company Executives

  • Name
  • Position
  • Salary
  • Lars Fruergaard Jorgensen
  • Chief Executive Officer and President
  • --
  • Karsten Munk Knudsen
  • Executive Vice President and Chief Financial Officer
  • 26.40M
  • Marcus Schindler, PhD
  • Executive Vice President, Research and Early Development and Chief Scientific Officer
  • 23.60M
  • Doug Langa
  • Executive Vice President, North America Operations
  • 2.20M
  • Martin Holst Lange
  • Executive Vice President, Development
  • 23.40M
  • Ludovic Helfgott
  • Executive Vice President, Rare Disease
  • 2.20M
  • Maziar Mike Doustdar
  • Executive Vice President, International Operations
  • 2.20M
  • Henrik Ehlers Wulff
  • Executive Vice President, Product Supply, Quality Assurance, Digital Data and IT
  • 25.90M
  • Camilla Sylvest
  • Executive Vice President, Commercial Strategy and Corporate Affairs
  • 23.40M
  • Henrik Poulsen
  • Vice Chairman of the Board
  • 2.40M
  • Helge Lund
  • Chairman of the Board
  • 3.90M
  • Mette Bojer Jensen
  • Director
  • 1.30M
  • Elisabeth Dahl Christensen
  • Director
  • 1.10M
  • Liselotte Hyveled
  • Director
  • 1.10M
  • Kasim Kutay
  • Director
  • 1.30M
  • Thomas Rantzau
  • Director
  • 1.10M
  • Dr. Martin W. Mackay, PhD
  • Independent Director
  • 1.80M
  • Christina Law
  • Independent Director
  • 1.70M
  • Dr. Sylvie Gregoire,Pharm.D.
  • Independent Director
  • 2.00M
  • Andreas Fibig
  • Independent Director
  • 1.40M
  • Laurence Debroux
  • Independent Director
  • 2.10M
  • David Moore
  • Executive Vice President, Corporate Development
  • 2.20M
  • Tania Sabroe
  • Executive Vice President, People and Organisation
  • 2.20M
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.